Compare Johnson & Johnson (JNJ) vs AT&T Inc. (T) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs AT&T Inc. — how do they compare? Johnson & Johnson trades at $261.49 (market cap $618.09B), while AT&T Inc. trades at $22.22 (market cap $170.42B). The key difference: Johnson & Johnson is far larger — about 3.6× AT&T Inc.'s market cap, and AT&T Inc. pays the higher dividend (4.46%). Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and AT&T Inc. for 118 Days on average.
| JNJ | T | |
|---|---|---|
Market Cap | $618.09B | $170.42B |
Volume | 6,050,983 | 50,780,036 |
Sector | Health | Media |
52-Week High | $278.43 | $29.10 |
52-Week Low | $186.00 | $20.49 |
Typical Hold Time | 129 Days | 118 Days |
Enterprise Value | $646.37B | $315.74B |
Dividend Yield | 2.09% | 4.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $261.44, up 1.16% with a bearish technical signal despite recent earnings beats. The company maintains strong fundamentals with $94.19B revenue, 21.48% net margin, and consistent dividend payments. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with a $286.53 consensus target.
JNJ offers stable growth potential with diversified healthcare operations and robust profitability. Key risks include patent expirations, competitive pressures, and debt levels. Analyst consensus leans bullish with 52.5% buy ratings, though technical indicators suggest near-term caution. The stock presents a balanced opportunity for long-term investors seeking healthcare exposure.
AT&T (T) trades at $22.18, down 9.38% in the past 24 hours, reflecting recent market pressure despite strong fundamentals. The company shows robust profitability with a 16.94% net income margin and attractive valuation metrics including a P/E of 8.21. Recent earnings beats and a $3 billion fiber deal with Corning highlight operational strength, while technical indicators show mixed signals with overall bullish sentiment.
The stock offers value with a consensus price target of $27.50, representing 24% upside potential. Key opportunities include fiber expansion and wireless growth, balanced against risks from heavy debt load and competitive pressures. The 4% dividend yield provides income support, though investors should monitor debt management and revenue trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About AT&T Inc.
AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.
Read more on T →
